HSIL Research Reports By Hem Securities & IndiaNivesh

With changing consumer preferences towards good quality and branded lifestyle products in line with higher disposable income, increasing penetration through wide distribution network, strong brand equity and expansion of product portfolio with right innovations bodes well for the growth of the company. We believe the company is trading at an attractive valuation at 19.39x and 16.59x of FY16EPS of Rs.15.62 and FY17EPS of Rs.18.26. We initiate a ‘BUY’ on the stock with a target price of Rs.400 (appreciation of about 32%) with the medium to long term investment horizon.

HSIL-Hem-Securities-Research-Report

HSIL-IndiaNivesh-Nov-15